WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

A ALIMENTARY TRACT AND METABOLISM
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A07A INTESTINAL ANTIINFECTIVES

This group comprises locally acting antiinfectives. Antiinfectives for systemic use, see J - Antiinfectives for systemic use.
See also P - Antiparasitic products, insecticides and repellents.


A07AA Antibiotics

Oral formulations of vancomycin and colistin are classified in this group as they are used in enterocolitis. Parenteral formulations of vancomycin are classified in J01XA - Glycopeptide antibacterials, and of colistin in J01XB - Polymyxins.
Most of the combined products containing more than one antibiotic, contain neomycin. Neomycin is given classification priority, thus all combined products containing neomycin and other antibiotics should be classified in A07AA51 - neomycin, combinations.
Paromomycin injection used in the treatment of leishmaniasis is classified here.

The DDDs are based on treatment of intestinal infections.

A07AB Sulfonamides

The DDDs are based on preoperative prophylaxis of intestinal infections.

A07AC Imidazole derivatives

The DDDs are based on treatment of gastrointestinal mycosis.

A07AX Other intestinal antiinfectives

This group comprises antiinfectives, which cannot be classified in A07AA-C.

Last updated: 2024-01-26